Wetzstein's research in the development of next-generation computational imaging, computational displays, and neural rendering systems has a wide range of applications in the fields of virtual and augmented reality, computer graphics, computer vision, microscopy, human-computer interaction, scientific imaging, health, and remote sensing.His research has, among other things, contributed to the development of near-eye displays that support perceptually important focus cues through varifocal, light field, and holographic display architectures.His lab has developed near-eye gaze tracking systems based on emerging event sensors that can achieve update rates of over 10 kHz with equivalent accuracy to high-end commercial desktop-mounted systems.Dr. Wetzstein's research has explored novel approaches to prescription correction, including autofocal eyeglasses for presbyopia correction that offer significant advantages over current progressive lenses as well as visioncorrecting direct-view displays.His research introduced a novel, thin form-factor wide-field-of-view glasses-free autostereoscopic "tensor" display built using stacks of time-multiplexed, backlit, light-attenuating LCD panels.He has led the development of new algorithms for computer-generated holography, enabling highquality, 3D, full-color holographic image synthesis in realtime ("neural holography") along with holographic near-eye display architectures with ultra-thin device form factors.Dr. Wetzstein co-founded two startup companies, Raxium and Zinn Labs, to accelerate the development of core technology of
No takes yet. Share an insight, caveat, or question.
Gordon Wetzstein (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: